TrialAnnals of oncology : official journal of the European Society for Medical Oncology2018

A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC).

L Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.